Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story
Abstract Insulin replacement therapy is mostly used by patients with type 2 diabetes who become insulin deficient and have failed other therapeutic options. They comprise about a quarter of those with diabetes, endures the majority of the complications and consumes the majority of the resources. Ade...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Clinical Diabetes and Endocrinology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40842-018-0056-5 |
id |
doaj-12bd75a7135443f78358429de1c0bd4c |
---|---|
record_format |
Article |
spelling |
doaj-12bd75a7135443f78358429de1c0bd4c2020-11-25T00:29:52ZengBMCClinical Diabetes and Endocrinology2055-82602018-04-014111110.1186/s40842-018-0056-5Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® storyI. Hodish0Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical CenterAbstract Insulin replacement therapy is mostly used by patients with type 2 diabetes who become insulin deficient and have failed other therapeutic options. They comprise about a quarter of those with diabetes, endures the majority of the complications and consumes the majority of the resources. Adequate insulin replacement therapy can prevent complications and reduce expenses, as long as therapy goals are achieved and maintained. Sadly, these therapy goals are seldom achieved and outcomes have not improved for decades despite advances in pharmacotherapy and technology. There is a growing recognition that the low success rate of insulin therapy results from intra-individual and inter-individual variations in insulin requirements. Total insulin requirements per day vary considerably between patients and constantly change without achieving a steady state. Thus, the key element in effective insulin therapy is unremitting and frequent dosage adjustments that can overcome those dynamics. In practice, insulin adjustments are done sporadically during outpatient clinic. Due to time constraints, providers are not able to deliver appropriate insulin dosage optimization. The d-Nav® Insulin Guidance Service has been developed to provide appropriate insulinization in insulin users without increasing the burden on healthcare systems. It relies on dedicated clinicians and a spectrum of technological solutions. Patients are provided with a handheld device called d-Nav® which advises them what dose of insulin to administer during each injection and automatically adjust insulin dosage when needed. The d-Nav care specialists periodically follow-up with users through telephone calls and in-person consultations to bestow user confidence, correct usage errors, triage, and identify uncharacteristic clinical courses. The following review provide details about the service and its clinical outcomes.http://link.springer.com/article/10.1186/s40842-018-0056-5Insulin therapyHypoglycemiaDosageType 2 diabetes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
I. Hodish |
spellingShingle |
I. Hodish Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story Clinical Diabetes and Endocrinology Insulin therapy Hypoglycemia Dosage Type 2 diabetes |
author_facet |
I. Hodish |
author_sort |
I. Hodish |
title |
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story |
title_short |
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story |
title_full |
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story |
title_fullStr |
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story |
title_full_unstemmed |
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story |
title_sort |
insulin therapy for type 2 diabetes – are we there yet? the d-nav® story |
publisher |
BMC |
series |
Clinical Diabetes and Endocrinology |
issn |
2055-8260 |
publishDate |
2018-04-01 |
description |
Abstract Insulin replacement therapy is mostly used by patients with type 2 diabetes who become insulin deficient and have failed other therapeutic options. They comprise about a quarter of those with diabetes, endures the majority of the complications and consumes the majority of the resources. Adequate insulin replacement therapy can prevent complications and reduce expenses, as long as therapy goals are achieved and maintained. Sadly, these therapy goals are seldom achieved and outcomes have not improved for decades despite advances in pharmacotherapy and technology. There is a growing recognition that the low success rate of insulin therapy results from intra-individual and inter-individual variations in insulin requirements. Total insulin requirements per day vary considerably between patients and constantly change without achieving a steady state. Thus, the key element in effective insulin therapy is unremitting and frequent dosage adjustments that can overcome those dynamics. In practice, insulin adjustments are done sporadically during outpatient clinic. Due to time constraints, providers are not able to deliver appropriate insulin dosage optimization. The d-Nav® Insulin Guidance Service has been developed to provide appropriate insulinization in insulin users without increasing the burden on healthcare systems. It relies on dedicated clinicians and a spectrum of technological solutions. Patients are provided with a handheld device called d-Nav® which advises them what dose of insulin to administer during each injection and automatically adjust insulin dosage when needed. The d-Nav care specialists periodically follow-up with users through telephone calls and in-person consultations to bestow user confidence, correct usage errors, triage, and identify uncharacteristic clinical courses. The following review provide details about the service and its clinical outcomes. |
topic |
Insulin therapy Hypoglycemia Dosage Type 2 diabetes |
url |
http://link.springer.com/article/10.1186/s40842-018-0056-5 |
work_keys_str_mv |
AT ihodish insulintherapyfortype2diabetesarewethereyetthednavstory |
_version_ |
1725329381052645376 |